| abstract |
A pharmaceutical composition useful for the prevention or treatment of increased urinary frequency or involuntary urination, comprising a compound of the general formula: (wherein R1 represents hydroxyl or lower alkoxy) or pharmacologically acceptable salt thereof and, used in combination therewith, an α1 adrenalin receptor blocking drug. |